A
$ Value
$0
Shares
645
Price
$0
Filed
May 1
Insider
Name
DEPARLE NANCY ANN
Title
—
CIK
0001144511
Roles
Director
Transaction Details
Transaction Date
2025-04-29
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
21,401
Footnotes
Represents common stock underlying 645 restricted share units attributable to an annual director equity award, which shall vest on the sooner of the date of the Issuer's 2026 annual shareholders' meeting or the first anniversary of the grant date.
Filing Info
DEPARLE NANCY ANN's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-04-29 | HCA | A | $0 |
Other Insiders at HCA (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| FRIST THOMAS F JR | — | — | 2026-02-06 |
|
HAZEN SAMUEL N
CEO
|
— | $21.5M | 2026-02-10 |
| FRIST THOMAS F III | — | — | 2026-02-06 |
| HERCULES HOLDING II | — | — | 2026-02-06 |
| Frisco Holding II | — | — | 2026-02-06 |
| Elcan Patricia F | — | — | 2026-02-06 |
| Frist William R | — | — | 2026-02-06 |
|
Foster Jon M
EVP and COO
|
— | — | 2026-02-10 |
|
Cuffe Michael S.
EVP and Chief Clinical Officer
|
— | $747K | 2026-02-10 |
|
Wyatt Christopher F.
SVP & Controller
|
— | $2.0M | 2026-02-11 |
|
Berres Jennifer
SVP & Chief Human Res. Officer
|
— | $4.1M | 2026-02-11 |
|
McAlevey Michael R
EVP & Chief Legal & Admin Off.
|
— | $904K | 2026-02-18 |
|
Marks Mike A
EVP and CFO
|
— | — | 2026-02-10 |
|
Rossitto Erica
SVP & Chief Nurse Executive
|
— | — | 2026-02-10 |